Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension
NCT02425566Phase 1Active, not recruiting
- Sponsor
- Vanderbilt University
- Start
- Apr 2015
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of trimethaphan and nitroglycerin in hypertension (HTN) (2 arms), sponsored by Vanderbilt University. Primary endpoint: Splanchnic venous capacitance at 10 minutes. Started Apr 2015; status: active, not recruiting.
02
Drugs
trimethaphannitroglycerin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02425566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02425566.